Kisqali vs. Kisqali Femara Co-Pack for Breast Cancer: Important Differences and Potential Risks.

Kisqali

(ribociclib)

Kisqali Femara Co-Pack

Summary for Kisqali

Prescription only

Kisqali (ribociclib) is a medication used to treat certain types of breast cancer, specifically hormone receptor–positive, human epidermal growth factor 2-negative (HR+, HER2-) breast cancer. It belongs to a drug class called CDK4/6 inhibitors, which help slow or stop cancer cells from growing. You typically take a tablet by mouth once a day for 21 days, then take 7 days off, repeating this 28-day cycle. It’s often taken together with other hormone treatments, like aromatase inhibitors or fulvestrant. Common side effects include feeling tired, nausea, and low white blood cell counts, which can make it easier to get infections.

Indications for Kisqali

Early breast cancer (HR+, HER2-), used with an aromatase inhibitor in adults at high risk of the cancer coming back
Advanced or metastatic breast cancer (HR+, HER2-), used with
- An aromatase inhibitor as the first hormone-based treatment OR
- Fulvestrant either as the first treatment or after the cancer has stopped responding to hormone-based treatment

Pros and Cons for Kisqali

Pros

Taken by mouth once a day
A first-choice treatment option for HR+, HER2- breast cancer
Can be taken with or without food

Cons

Common side effects include nausea, tiredness, and headache
Requires regular blood tests to monitor for side effects
Interacts with many medications

Common Side Effects for Kisqali

Early breast cancer

Lower white blood cell counts (up to 97%)
Lower red blood cell counts (47%)
Higher liver enzymes (up to 45%)
Infections (37%)
Higher creatinine levels (33%)
Lower platelets (28%)
Headache (23%)
Nausea (23%)
Tiredness (22%)

Advanced or metastatic breast cancer

Lower white blood cell counts (up to 95%)
Lower red blood cell counts (68%)
Higher liver enzymes (up to 55%)
Nausea (47%)
Infections (47%)
Higher creatinine levels (42%)
Tiredness (35%)
Low red blood cell count
Lower appetite
Dizziness
Trouble sleeping
Trouble breathing
Swollen or sore mouth
Stomach pain
Fever
Pain or swelling in arms or legs
Liver problems
Lower platelets (34%)
Diarrhea (33%)
Vomiting (29%)
Headache (27%)
Constipation (25%)
Hair loss (25%)
Cough (24%)
Rash (24%)
Back pain (24%)
Lower blood sugar (20%)

Note: Side effects listed above were reported in studies where people took Kisqali (ribociclib) with another hormone medication.

Warnings for Kisqali

Lung problems
Severe skin reactions
Heart rhythm problem (QT prolongation)
Liver problems
Low white blood cell counts
Harm to unborn baby

Summary for Kisqali Femara Co-Pack

Prescription only

Kisqali Femara Co-Pack is a combination medication used to treat certain types of breast cancer, specifically hormone receptor–positive, human epidermal growth factor 2-negative (HR+, HER2-) breast cancer. It contains two medications: Kisqali (ribociclib), a CDK4/6 inhibitor, and Femara (letrozole), an aromatase inhibitor. You take Kisqali once a day for 21 days, then take 7 days off, in a 28-day cycle. Femara is taken once a day with no breaks. Common side effects include feeling tired, nausea, and low white blood cell counts, which can make it easier to get infections.

Indications for Kisqali Femara Co-Pack

Early breast cancer (HR+, HER2-) in adults at high risk of the cancer coming back
Advanced or metastatic breast cancer (HR+, HER2-) as the first hormone-based treatment

Pros and Cons for Kisqali Femara Co-Pack

Pros

Combines two medications in one package
Pills are taken by mouth
A first-choice treatment option for HR+, HER2- breast cancer

Cons

Common side effects include nausea, tiredness, and headache
Requires regular blood tests to monitor for side effects
Interacts with many medications

Common Side Effects for Kisqali Femara Co-Pack

Early breast cancer

Lower white blood cell counts (up to 97%)
Lower red blood cell counts (47%)
Higher liver enzymes (up to 45%)
Infections (37%)
Higher creatinine levels (33%)
Lower platelets (28%)
Headache (23%)
Nausea (23%)
Tiredness (22%)

Advanced or metastatic breast cancer

Lower white blood cell counts (up to 94%)
Lower red blood cell counts (72%)
Higher liver enzymes (up to 53%)
Infections (46%)
Nausea (46%)
Tiredness (36%)
Lower platelets (34%)
Diarrhea (33%)
Headache (29%)
Hair loss (29%)
Vomiting (29%)
Back pain (25%)
Constipation (25%)
Cough (24%)
Rash (22%)
Higher creatinine levels (20%)
Stomach pain (20%)

Warnings for Kisqali Femara Co-Pack

Lung problems
Severe skin reactions
Heart rhythm problem (QT prolongation)
Liver problems
Low white blood cell counts
Harm to unborn baby

Prices with our coupons for Kisqali vs. Kisqali Femara Co-Pack

Kisqali1 carton / 42 tablets of 400mg/day

$16,327.71-

Get free coupons

More Information

Kisqali/Femara1 carton / co-pack of 200mg daily dose/2.5mg

$6,797.41-

Get free coupons

More Information

Compare other Breast Cancer drugs

Kisqali vs. Ibrance Kisqali vs. Verzenio Ibrance vs. Verzenio

Browse medications by letter

Show All

Browse prescription and over-the-counter medications from A to Z, compare drug prices, and start saving.

Compare
Kisqali vs. Kisqali Femara Co-Pack

Kisqali

Kisqali Femara Co-Pack

Summary for Kisqali

Indications for Kisqali

Pros and Cons for Kisqali

Pros

Cons

Common Side Effects for Kisqali

Warnings for Kisqali

Summary for Kisqali Femara Co-Pack

Indications for Kisqali Femara Co-Pack

Pros and Cons for Kisqali Femara Co-Pack

Pros

Cons

Common Side Effects for Kisqali Femara Co-Pack

Warnings for Kisqali Femara Co-Pack

Prices with our coupons for Kisqali vs. Kisqali Femara Co-Pack

Compare other Breast Cancer drugs

Browse medications by letter

Good news for your inbox

Kisqali

Kisqali Femara Co-Pack

Summary for Kisqali

Indications for Kisqali

Pros and Cons for Kisqali

Pros

Cons

Common Side Effects for Kisqali

Warnings for Kisqali

Summary for Kisqali Femara Co-Pack

Indications for Kisqali Femara Co-Pack

Pros and Cons for Kisqali Femara Co-Pack

Pros

Cons

Common Side Effects for Kisqali Femara Co-Pack

Warnings for Kisqali Femara Co-Pack